1. Jindaphun K, Takheaw N, Laopajon W, Pata S, Kasinrerk W. Toxicity effects of Cannabidiol (CBD) on immune cells. J Assoc Med Sci 2024;57(1):87-95.

2. Takheaw N, Jindaphun K, Pata S, Laopajon W, Kasinrerk W. Cannabinoid receptor 1 agonist ACEA and cannabinoid receptor 2 agonist GW833972A attenuates cell-mediated immunity by different biological mechanisms. Cells 2023;12(6):848. doi 10.3390/cells12060848.

3. Liwsrisakun C, Pata S, Laopajon W, Takheaw N, Chaiwong W, Duangjit P, Inchai J, Chuensirikulchai K, Cheyasawan P, Pothirat C, Bumroongkit C, Deesomchok A, Theerakittikul T, Limsukon A, Tajarernmuang P, Niyatiwatchanchai N, Trongtrakul K, Kasinrerk W. Humoral and cellular immune responses against SARS-CoV-2 variants of concern induced by heterologous CoronaVac/ChAdOx-1 versus homologous ChAdOx-1 vaccination in the elderly. Asian Pac J Allergy Immunol 2023;-(-):doi 10.12932/AP-120822-1434.

4. Tantakitti F, Pata S, Laopajon W, Kasinrerk W, Hidalgo-Bastida A. Production of high-value proteins under stringent cost constraints-The case of hollow fiber technology for cell culture. Processes 2023;11(3):889. doi 10.3390/pr11030889.

5. Takheaw N, Liwsrisakun C, Laopajon W, Pata S, Chiwong W, Inchai J, Duangjit P, Pothirat C, Bumroongkit C, Deesomchok A, Theerakittikul T, Limsukon A. Levels and durability of neutralizing antibodies against SARS-CoV-2 Omicron and other variants after ChAdOx-1 or BNT162b2 booster in CoronaVac-primed elderly individuals. Heliyon 2023;9(4):e15653. doi 10.1016/j.heliyon.2023.e15653.

6. Chaiwong W, Takheaw N, Pata S, Laopajon W, Duangjit P, Inchai J, Pothirat C, Bumroongkit C, Deesomchok A, Theerakittijul T, Limsukon A, Tajarernmuang P. Neutralizing antibody and T-cell responses against SARS-CoV-2 variants by heterologous CoronaVac/ChAdOx-1 vaccination in elderly subjects with chronic obstructive pulmonary disease. Vaccines 2023;41(40):5901–9.

7. Liwsrisakun C, Pata S, Laopajon W, Takheaw N, Chaiwong W, Inchai J, Pothirat C, Bumroongkit C, Deesomchok A, Theerakittikul T, Limsukon A, Tajarernmuang P, Niyatiwatchanchai N, Trongtrakul K, Chuensirikulchai K. Neutralizing antibody and T cell responses against SARS-CoV-2 variants of concern following ChAdOx-1 or BNT162b2 boosting in the elderly previously immunized with CoronaVac vaccine. Immun Ageing 2022;19(1):24. doi 10.1186/s12979-022-00279-8.

8. Pomlok K, Pata S, Kulaphisit M, Pangnuchar R, Wipasa J, Smith DR, Kasinrerk W, Lithanatudom P. An IgM monoclonal antibody against domain 1 of CD147 induces non-canonical RIPK-independent necroptosis in a cell type specific manner in hepatocellular carcinoma cells. Biochim Biophys Acta Mol Cell Res 2022;1869(9):119295. doi 10.1016/j.bbamcr.2022.119295..

9. Yadoung S, Ishimatsu R, Xu ZL, Sringarm K, Pata S, Thongkham M, Chantara S, Pattarawarapan M, Hongsibsong S. Development of IgY-based Indirect competitive ELISA for the detection of fluoroquinolone residues in chicken and pork samples. Antibiotics (Basel) 2022;11(11):1512. doi 10.3390/antibiotics11111512.

10. Thu MM, Takheaw N, Laopajon W, Pata S. Optimization of culture conditions for stable expression of recombinant fc-fused human extracellular CD99 in HEK293T cells. Protein Expr Purif 2022;200(-):106151. doi 10.1016/j.pep.2022.106151.

11. Takheaw N, Liwsrisakun C, Chaiwong W, Laopajon W, Pata S, Inchai J, Duangjit P, Pothirat C, Bumroongkit C, Deesomchok A, Theerakittkul T, Limsukon A, Tajarernmuang P, Niyatiwatchanchai N, Trongtrakul K, Kasinrerk W. Correlation Analysis of Anti-SARS-CoV-2 RBD IgG and Neutralizing Antibody against SARS-CoV-2 Omicron Variants after Vaccination. Diagnostics (Basel) 2022;12(6):1315. doi 10.3390/diagnostics12061315.

12. Chaiwong W, Takheaw N, Laopajon W, Pata S, Duangjit P, Inchai J, Pothirat C, Bumroongkit C, Deesomchok A, Theerakittijul T, Limsukon A, Tajarernmuang P. Neutralizing antibody and T-cell responses against SARS-CoV-2 wild-type and variants of concern in chronic obstructive pulmonary disease subjects after ChAdOx-1/ChAdOx-1 homologous vaccination: A preliminary study. Vaccines 2022;10(2):2176. doi 10.3390/vaccines10122176.

13. Pata S, Surinkaew S, Takheaw N, Laopajon W, Chuensirikulchai K, Kasinrerk W. . Front Immunol 2021;12(-):704309. doi 10.3389/fimmu.2021.704309.

14. Leitner J, Mahasongkram K, Schatzlmaier P, Pfisterer K, Leksa V, Pata S, Kasinrerk W, Stockinger H, Steinberger P. Differentiation and activation of human CD4 T cells is associated with a gradual loss of myelin and lymphocyte protein. Eur J Immunol 2021;51(4):848-63.

15. Takheaw N, Pata S, Laopajon W, Roytrakul S, Kasinrerk W. . BMC Res Notes 2020;13(1):496. doi 10.1186/ s13104-020-05347-0.